Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Tagawa

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Blood|February 18, 2006
Identification of subtype-specific genomic alterations in aggressive adult T-cell leukemia/lymphomaAya Oshiro, Hiroyuki Tagawa, Koichi Ohshima, et al.
Cancer Science|February 7, 2017
Hypoxia-inducible microRNA-210 regulates the DIMT1-IRF4 oncogenic axis in multiple myelomaSho Ikeda, Akihiro Kitadate, Fumito Abe, et al.
Plos One|March 8, 2013
Bortezomib reduces the tumorigenicity of multiple myeloma via downregulation of upregulated targets in clonogenic side population cellsMiho Nara, Kazuaki Teshima, Atsushi Watanabe, et al.
Blood|November 4, 2011
Enucleation of human erythroblasts involves non-muscle myosin IIBKumi Ubukawa, Yong-Mei Guo, Masayuki Takahashi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 16, 2013
[Adult T-cell leukemia-lymphoma developed from an HTLV-1 carrier during treatment of B-cell lymphoma-associated hemophagocytic syndrome]Takayo Nagao, Naoto Takahashi, Hirobumi Saitoh, et al.
Cancer Research|September 3, 2004
Genome-wide array-based comparative genomic hybridization of diffuse large B-cell lymphoma: comparison between CD5-positive and CD5-negative casesHiroyuki Tagawa, Shinobu Tsuzuki, Ritsuro Suzuki, et al.
Blood|July 31, 2009
Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemiaYasuo Yamanaka, Hiroyuki Tagawa, Naoto Takahashi, et al.
Therapeutic Drug Monitoring|February 25, 2014
A limited sampling model to estimate exposure to lenalidomide in multiple myeloma patientsSeiji Shida, Naoto Takahashi, Masatomo Miura, et al.
Cancer Science|February 3, 2007
Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32Tetsuo Taniguchi, Sivasundaram Karnan, Takayuki Fukui, et al.
Cancer Chemotherapy and Pharmacology|May 25, 2016
Effects of CYP3A5 polymorphism on the pharmacokinetics of a once-daily modified-release tacrolimus formulation and acute kidney injury in hematopoietic stem cell transplantationTakaya Yamashita, Naohito Fujishima, Masatomo Miura, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Blood|February 18, 2006
Identification of subtype-specific genomic alterations in aggressive adult T-cell leukemia/lymphomaAya Oshiro, Hiroyuki Tagawa, Koichi Ohshima, et al.
Cancer Science|February 7, 2017
Hypoxia-inducible microRNA-210 regulates the DIMT1-IRF4 oncogenic axis in multiple myelomaSho Ikeda, Akihiro Kitadate, Fumito Abe, et al.
Plos One|March 8, 2013
Bortezomib reduces the tumorigenicity of multiple myeloma via downregulation of upregulated targets in clonogenic side population cellsMiho Nara, Kazuaki Teshima, Atsushi Watanabe, et al.
Blood|November 4, 2011
Enucleation of human erythroblasts involves non-muscle myosin IIBKumi Ubukawa, Yong-Mei Guo, Masayuki Takahashi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 16, 2013
[Adult T-cell leukemia-lymphoma developed from an HTLV-1 carrier during treatment of B-cell lymphoma-associated hemophagocytic syndrome]Takayo Nagao, Naoto Takahashi, Hirobumi Saitoh, et al.
Cancer Research|September 3, 2004
Genome-wide array-based comparative genomic hybridization of diffuse large B-cell lymphoma: comparison between CD5-positive and CD5-negative casesHiroyuki Tagawa, Shinobu Tsuzuki, Ritsuro Suzuki, et al.
Blood|July 31, 2009
Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemiaYasuo Yamanaka, Hiroyuki Tagawa, Naoto Takahashi, et al.
Therapeutic Drug Monitoring|February 25, 2014
A limited sampling model to estimate exposure to lenalidomide in multiple myeloma patientsSeiji Shida, Naoto Takahashi, Masatomo Miura, et al.
Cancer Science|February 3, 2007
Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32Tetsuo Taniguchi, Sivasundaram Karnan, Takayuki Fukui, et al.
Cancer Chemotherapy and Pharmacology|May 25, 2016
Effects of CYP3A5 polymorphism on the pharmacokinetics of a once-daily modified-release tacrolimus formulation and acute kidney injury in hematopoietic stem cell transplantationTakaya Yamashita, Naohito Fujishima, Masatomo Miura, et al.
Pageof 8